Skåne University Hospital

Malmö SE-20502

4 studies enrolling now · 9 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Arrhythmogenic Right Ventricular Cardiomyopathy, Chronic Coronary Disease, Hemophilia A, Hemophilia B, Prostate Cancer Recurrent, Surgical and the Percutaneous Approach to the Upper Extremity Access, Von Willebrand Disease

Studies at this site

• Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively — Recruiting now
• One-Month DAPT in CABG Patients — Recruiting now
• Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients — Recruiting now
• Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) — Recruiting now
• A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) — Completed
• SUrgical Versus PERcutaneous AXillary Artery International Registry — Completed
• Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer — Running, not enrolling
• Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease — Completed
• The Von Willebrand Disease (VWD) International Prophylaxis Study — Completed